第59回日本神経学会学術大会
2018年5月23日〜5月26日ロイトン札幌・さっぽろ芸術文化の館・札幌市教育文化会館
第59回日本神経学会学術大会
2018年5月23日〜5月26日ロイトン札幌・さっぽろ芸術文化の館・札幌市教育文化会館
[EANF-01-4]Dissecting the neurovirulence and viscerotropism determinants of Japanese Encephalitis virus
○Cheng-Feng Qin1,2(1.Department of Virology, Beijing Institute of Microbiology and Epidemiology, 2.State Key Laboratory of Pathogen and Biosecurity, Beijing 100071)
Cheng-Feng Qin obtained his B.Sc. degree in Microbiology in Wuhan University, and Ph.D degree in Microbiology in Academy of Military Medical Sciences. His primary research interests focus on the pathogenesis and vaccine development of mosquito-borne flavivirus. Current ongoing projects include: 1) to identify and characterize viral virulence determinants and regulatory RNA elements; 2) to rationally design live-attenuated vaccine by reverse genetic technology; and 3) to improve vaccine stability and efficacy by using genetic and chemical methods.
Cheng-Feng Qin has been awarded as the Newton Advanced Fellowship from the UK Academy of Medical Sciences, the Young Investigator Program from the Edward Jenner Vaccine Society, the National Excellent Young Scientist Program of NSFC, the joint Award of Institute Merieux and Chinese Society of Microbiology, and the ADVAC fellowship from Foundation Merieux.
He has published more than 80 peer-reviewed papers in Science, Immunity, Lancet Infect Dis, eLife, Cell Stem Cell, Cell Host Microbes, PNAS, Nature Commun, Cell Res, J Virol, etc and held a dozen of national and PCT patents on vaccine candidate and related technologies. He also serves as the editor or editorial board member of several international journals including Scientific Reports, BMC Infectious Diseases, npj Vaccines, Virol Sin, etc.
Cheng-Feng Qin has been awarded as the Newton Advanced Fellowship from the UK Academy of Medical Sciences, the Young Investigator Program from the Edward Jenner Vaccine Society, the National Excellent Young Scientist Program of NSFC, the joint Award of Institute Merieux and Chinese Society of Microbiology, and the ADVAC fellowship from Foundation Merieux.
He has published more than 80 peer-reviewed papers in Science, Immunity, Lancet Infect Dis, eLife, Cell Stem Cell, Cell Host Microbes, PNAS, Nature Commun, Cell Res, J Virol, etc and held a dozen of national and PCT patents on vaccine candidate and related technologies. He also serves as the editor or editorial board member of several international journals including Scientific Reports, BMC Infectious Diseases, npj Vaccines, Virol Sin, etc.
閲覧にはパスワードが必要です
抄録パスワード認証
パスワードは抄録集・参加証に記載してあります。
パスワードは抄録集・参加証に記載してあります。